Next Article in Journal
A Ceramic Foam Structure Design with the Valorization of Fly Ash Cenospheres: A Promising Avenue for Sustainable Bioscaffolds
Previous Article in Journal
RarE Neuropediatric Diseases Electronic Registry (RENDER): Toward a Unified, High-Resolution Disease Registry
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Proceedings
Volume 120
Issue 1
10.3390/proceedings2025120009
proceedings-logo
Submit to this Journal
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Microvascular and Blood–Brain Barrier Dysfunction in COL4A1-Related cSVD Can Be Identified by MR DSC Perfusion Imaging †

by
Diana Tambala
1,2,‡,
John P. Snow
1,3,‡,
Daniel Balentine
4,
Karl G. Helmer
4,5,
Kenda Alhadid
1,2,3,
Patricia L. Musolino
1,2,3,* and
Arne Lauer
6
1
Department of Neurology, Massachusetts General Hospital, Boston, MA 02214, USA
2
Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02214, USA
3
Department of Neurology, Harvard Medical School, Boston, MA 02214, USA
4
Department of Radiology and Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA 02214, USA
5
Department of Radiology, Harvard Medical School, Boston, MA 02214, USA
6
Department of Neuroradiology, University of Heidelberg, 69210 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
†
Presented at the 2nd COL4A1-A2 International Conference, Rome, Italy, 10 February 2025.
‡
These authors contributed equally to this work.
Proceedings 2025, 120(1), 9; https://doi.org/10.3390/proceedings2025120009
Published: 14 July 2025
Versions Notes

Introduction: Pathogenic variants in COL4A1 compromise basement membrane integrity, leading to cerebral small vessel disease (cSVD) characterized by white matter hyperintensities (WMHs), microbleeds, and ischemic or hemorrhagic strokes [1,2,3]. Despite the clinical impact, no imaging biomarkers currently exist to assess disease severity or predict stroke risk in COL4A1-related cSVD. In this study, we evaluated microvascular flow heterogeneity and blood–brain barrier (BBB) permeability using dynamic susceptibility contrast (DSC) MR perfusion imaging [4].
Methods: We retrospectively analyzed five Dynamic Susceptibility Contrast Magnetic Resonance (DSC MR) perfusion imaging studies from four patients with symptomatic COL4A1 mutations (p.G212A, p.G1248R, p.G1242D). Three patients (one with p.G212A and two with p.G1248R) had a single imaging study, while one patient with p.G1242D underwent imaging at two distinct timepoints. The mean age of the COL4A1 cohort was 33.42 years (range: 6.2–47.6 years). For comparison, we included ten age-matched control patients (mean age: 53.6 years; range: 28–74 years) who underwent DSC MR perfusion imaging and showed no evidence of cerebrovascular abnormalities. DSC data were processed using Cercare® software perfusion toolbox v1.0 to extract capillary transit time heterogeneity (CTH), apparent leakage constant (Kapp), oxygen extraction capacity (OEC), and cerebral metabolic rate of oxygen (CMRO2 max). Brain regions were segmented into WMH, normal-appearing white matter (NAWM), and gray matter (GM) using a 3D Slicer 5.4.0. Statistical analyses included unpaired t-tests and one-way ANOVA.
Results: Compared to the controls, COL4A1 patients exhibited significantly increased BBB permeability (Kapp) across all brain regions (p < 0.0001). CTH was elevated in WMH (p = 0.0014) and NAWM (p = 0.0036) but reduced in GM (p = 0.0217). Within COL4A1 patients, WMH regions showed higher CTH, greater OEC, and lower CMRO2 max compared to NAWM, indicating more severe microvascular dysfunction.
Conclusions: These results demonstrate that DSC-MRI perfusion imaging sensitively detects global and regional microvascular abnormalities in COL4A1-related cSVD. Elevated Kapp and altered CTH may serve as promising imaging biomarkers for risk stratification, disease monitoring, and therapeutic evaluation in this population.

Author Contributions

Contributed to the study concept and design, analysis and interpretation of data, and drafting of the manuscript, D.T., J.P.S. and A.L.; responsible for data collection, analysis and interpretation of data, and drafting of the manuscript, D.T. and A.L.; contributed to the analysis and interpretation of data, D.B. and A.L.; provided critical revision of the manuscript for important intellectual content, K.G.H. and K.A.; contributed to the study concept and design, analysis and interpretation of data, drafting of the manuscript, and supervised the study, P.L.M. All authors have read and agreed to the published version of the manuscript.

Funding

This manuscript received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Massachusetts General Hospital IRB protocol #2018P002134.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data supporting the findings of this study are not publicly available due to privacy and ethical restrictions. However, de-identified data may be made available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Plaisier, E.; Ronco, P. COL4A1-Related Disorders. In GeneReviews; Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Amemiya, A., Eds.; University of Washington, WA, USA, 1993–2005. Available online: https://www.ncbi.nlm.nih.gov/books/NBK7046/ (accessed on 9 July 2025).
  2. Lanfranconi, S.; Markus, H.S. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: A systematic review. Stroke 2010, 41, e513–e518. [Google Scholar] [CrossRef] [PubMed]
  3. Zagaglia, S.; Selch, C.; Nisevic, J.R.; Mei, D.; Michalak, Z.; Hernandez-Hernandez, L.; Krithika, S.; Vezyroglou, K.; Varadkar, S.M.; Pepler, A.; et al. Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. Neurology 2018, 91, e2078–e2088. [Google Scholar] [CrossRef]
  4. Lauer, A.; Da, X.; Hansen, M.B.; Boulouis, G.; Ou, Y.; Cai, X.; Liberato Celso Pedrotti, A.; Kalpathy-Cramer, J.; Caruso, P.; Hayden, D.L.; et al. ABCD1 dysfunction alters white matter microvascular perfusion. Brain 2017, 140, 3139–3152. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tambala, D.; Snow, J.P.; Balentine, D.; Helmer, K.G.; Alhadid, K.; Musolino, P.L.; Lauer, A. Microvascular and Blood–Brain Barrier Dysfunction in COL4A1-Related cSVD Can Be Identified by MR DSC Perfusion Imaging. Proceedings 2025, 120, 9. https://doi.org/10.3390/proceedings2025120009

AMA Style

Tambala D, Snow JP, Balentine D, Helmer KG, Alhadid K, Musolino PL, Lauer A. Microvascular and Blood–Brain Barrier Dysfunction in COL4A1-Related cSVD Can Be Identified by MR DSC Perfusion Imaging. Proceedings. 2025; 120(1):9. https://doi.org/10.3390/proceedings2025120009

Chicago/Turabian Style

Tambala, Diana, John P. Snow, Daniel Balentine, Karl G. Helmer, Kenda Alhadid, Patricia L. Musolino, and Arne Lauer. 2025. "Microvascular and Blood–Brain Barrier Dysfunction in COL4A1-Related cSVD Can Be Identified by MR DSC Perfusion Imaging" Proceedings 120, no. 1: 9. https://doi.org/10.3390/proceedings2025120009

APA Style

Tambala, D., Snow, J. P., Balentine, D., Helmer, K. G., Alhadid, K., Musolino, P. L., & Lauer, A. (2025). Microvascular and Blood–Brain Barrier Dysfunction in COL4A1-Related cSVD Can Be Identified by MR DSC Perfusion Imaging. Proceedings, 120(1), 9. https://doi.org/10.3390/proceedings2025120009

Article Metrics

Back to TopTop